-
1
-
-
0031000336
-
Frequency of immune thrombocytopenia in newborns: A prospective study
-
Dreyfus M, Kaplan C, Verdy E, et al. Frequency of immune thrombocytopenia in newborns: a prospective study. Blood. 1997;89(12):4402-4406. (Pubitemid 27260250)
-
(1997)
Blood
, vol.89
, Issue.12
, pp. 4402-4406
-
-
Dreyfus, M.1
Kaplan, C.2
Verdy, E.3
Schlegel, N.4
Durand-Zaleski, I.5
Tchernia, G.6
-
2
-
-
78149300934
-
Animal model of fetal and neonatal immune thrombocytopenia: Role of neonatal Fc receptor in the pathogenesis and therapy
-
Chen P, Li C, Lang S, et al. Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy. Blood. 2010;116(18):3660-3668.
-
(2010)
Blood
, vol.116
, Issue.18
, pp. 3660-3668
-
-
Chen, P.1
Li, C.2
Lang, S.3
-
3
-
-
0030468012
-
Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: A prospective comparison of effectiveness and costs
-
Durand-Zaleski I, Schlegel N, Blum-Boisgard C, et al. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Am J Perinatol. 1996;13(7):423-431. (Pubitemid 26425206)
-
(1996)
American Journal of Perinatology
, vol.13
, Issue.7
, pp. 423-431
-
-
Durand-Zaleski, I.1
Schlegel, N.2
Blum-Boisgard, C.3
Uzan, S.4
Dreyfus, M.5
Kaplan, C.6
-
4
-
-
0024523915
-
348 cases of suspected neonatal alloimmune thrombocytopenia
-
Mueller-Eckhardt C, Kiefel V, Grubert A, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet. 1989;1(8634):363-366. (Pubitemid 19103082)
-
(1989)
Lancet
, vol.1
, Issue.8634
, pp. 363-366
-
-
Mueller-Eckhardt, C.1
Grubert, A.2
Weisheit, M.3
Mueller-Eckhardt, G.4
Kiefel, V.5
Kroll, H.6
Schmidt, S.7
Santoso, S.8
-
5
-
-
34548439081
-
Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: A randomized controlled trial
-
Berkowitz RL, Lesser ML, McFarland JG, et al. Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial. Obstet Gynecol. 2007;110(2 Pt 1):249-255.
-
(2007)
Obstet Gynecol
, vol.110
, Issue.2 PART 1
, pp. 249-255
-
-
Berkowitz, R.L.1
Lesser, M.L.2
McFarland, J.G.3
-
6
-
-
48749129395
-
Developing recombinant HPA-1a-specific antibodies with abrogated Fc-gamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia
-
Ghevaert C, Wilcox DA, Fang J, et al. Developing recombinant HPA-1a-specific antibodies with abrogated Fc-gamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia. J Clin Invest. 2008;118(8):2929-2938.
-
(2008)
J Clin Invest
, vol.118
, Issue.8
, pp. 2929-2938
-
-
Ghevaert, C.1
Wilcox, D.A.2
Fang, J.3
-
7
-
-
33645531319
-
A novel murine model of fetal and neonatal alloimmune thrombocytopenia: Response to intravenous IgG therapy
-
Ni H, Chen P, Spring CM, et al. A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy. Blood. 2006;107(7):2976-2983.
-
(2006)
Blood
, vol.107
, Issue.7
, pp. 2976-2983
-
-
Ni, H.1
Chen, P.2
Spring, C.M.3
-
8
-
-
0015421358
-
The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat
-
Jones EA, Waldmann TA. The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J Clin Invest. 1972;51(11):2916-2927.
-
(1972)
J Clin Invest
, vol.51
, Issue.11
, pp. 2916-2927
-
-
Jones, E.A.1
Waldmann, T.A.2
-
9
-
-
77954680599
-
The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases
-
Sesarman A, Vidarsson G, Sitaru C. The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases. Cell Mol Life Sci. 2010;67(15):2533-2550.
-
(2010)
Cell Mol Life Sci
, vol.67
, Issue.15
, pp. 2533-2550
-
-
Sesarman, A.1
Vidarsson, G.2
Sitaru, C.3
-
10
-
-
40749083596
-
The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: What do we really know?
-
Crow AR, Lazarus AH. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know? Transfus Med Rev. 2008;22(2):103-116.
-
(2008)
Transfus Med Rev
, vol.22
, Issue.2
, pp. 103-116
-
-
Crow, A.R.1
Lazarus, A.H.2
|